Please use this identifier to cite or link to this item: https://ir.iimcal.ac.in:8443/jspui/handle/123456789/1845
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChaudhuri, Sudip
dc.date.accessioned2021-08-26T07:05:30Z-
dc.date.available2021-08-26T07:05:30Z-
dc.date.issued2013
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84876817537&partnerID=40&md5=49cd24dc83af82dcaa0e8618cf2ba60c
dc.identifier.urihttps://ir.iimcal.ac.in:8443/jspui/handle/123456789/1845-
dc.descriptionChaudhuri, Sudip, Indian Institute of Management Calcutta, India
dc.descriptionISSN/ISBN - 129976
dc.descriptionpp.10-12
dc.description.abstractThe Supreme Court judgment on the Novartis-Glivec case is remarkable because it has gone beyond the specifi c technical and legal issues surrounding patents and has put the matter in a much larger political and economic perspective. The deeper implication of the judgment is that it is not only justifi ed to deny patents when incremental innovation is trivial as in the Glivec case. The judgment has linked the entire question of patenting with net benefi ts to society and has highlighted the relevance of specifi c conditions of a country for deciding the appropriate patent regime. What the judgment says and what it implies has tremendous signifi cance for the patent regimes in developing countries beyond the secondary patenting issues.
dc.publisherSCOPUS
dc.publisherEconomic and Political Weekly
dc.relation.ispartofseries48(17)
dc.titleThe larger implications of the Novartis-Glivec judgment
dc.typeReview
Appears in Collections:Economics

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.